相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study
Olof R. Hjorth et al.
MOLECULAR PSYCHIATRY (2021)
Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial
Olof R. Hjorth et al.
TRANSLATIONAL PSYCHIATRY (2021)
Serotonin transporter availability increases in patients recovering from a depressive episode
Jonas E. Svensson et al.
TRANSLATIONAL PSYCHIATRY (2021)
Consequences of the monoaminergic systems cross-talk in the antidepressant activity
L. Tritschler et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2018)
The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs
Piotr Galecki et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis
Per Carlbring et al.
COGNITIVE BEHAVIOUR THERAPY (2018)
Anterior cingulate cortex activity as a candidate biomarker for treatment selection in social anxiety disorder
Andreas Frick et al.
BJPSYCH OPEN (2018)
Extrastriatal dopamine D2-receptor availability in social anxiety disorder
Pontus Plaven-Sigray et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Social Anxiety Disorder
Falk Leichsenring et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Caudal Nucleus Accumbens Core Is Critical in the Regulation of Cue-Elicited Approach-Avoidance Decisions
Laurie Hamel et al.
ENEURO (2017)
Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial
Malin Gingnell et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder
Andreas Frick et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123I]β-CIT SPECT study
A. Rominger et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Serotonin Synthesis and Reuptake in Social Anxiety Disorder A Positron Emission Tomography Study
Andreas Frick et al.
JAMA PSYCHIATRY (2015)
THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION
C. P. Ford
NEUROSCIENCE (2014)
Reduced 5-HT1B receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder
Mikael Tiger et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2014)
Association between amygdala reactivity and a dopamine transporter gene polymorphism
O. Bergman et al.
TRANSLATIONAL PSYCHIATRY (2014)
Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis
Evan Mayo-Wilson et al.
LANCET PSYCHIATRY (2014)
Have No Fear: The Neural Basis of Anxiolytic Drug Action in Generalized Social Phobia
Catherine J. Harmer
BIOLOGICAL PSYCHIATRY (2013)
Change Over Time in Brain Serotonin Transporter Binding in Major Depression: Effects of Therapy Measured with [123I]-ADAM SPECT
Jay D. Amsterdam et al.
JOURNAL OF NEUROIMAGING (2013)
The nucleus accumbens is involved in both the pursuit of social reward and the avoidance of social punishment
Gregor Kohls et al.
NEUROPSYCHOLOGIA (2013)
Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder
Heide Klumpp et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Altered neural correlates of affective processing after internet-delivered cognitive behavior therapy for social anxiety disorder
Kristoffer N. T. Mansson et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2013)
Dopamine agonist-responsive depression
Hiroaki Hori et al.
PSYCHOGERIATRICS (2013)
Predicting Treatment Response in Social Anxiety Disorder From Functional Magnetic Resonance Imaging
Oliver Doehrmann et al.
JAMA PSYCHIATRY (2013)
Impact of Cognitive Behavioral Therapy for Social Anxiety Disorder on the Neural Dynamics of Cognitive Reappraisal of Negative Self-beliefs Randomized Clinical Trial
Philippe R. Goldin et al.
JAMA PSYCHIATRY (2013)
Anxiety in Parkinson's disease: A critical review of experimental and clinical studies
Rui D. S. Prediger et al.
NEUROPHARMACOLOGY (2012)
Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram
J. M. Warwick et al.
METABOLIC BRAIN DISEASE (2012)
Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder
S. Cervenka et al.
TRANSLATIONAL PSYCHIATRY (2012)
Serotonin Transporter Occupancy and the Functional Neuroanatomic Effects of Citalopram in Geriatric Depression
Gwenn S. Smith et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder
Tais S. Moriyama et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Internet-Based Cognitive Behavior Therapy vs. Cognitive Behavioral Group Therapy for Social Anxiety Disorder: A Randomized Controlled Non-inferiority Trial
Erik Hedman et al.
PLOS ONE (2011)
Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats
Yuji Kitaichi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Dopaminergic challenges in social anxiety disorder: evidence for dopamine D-3 desensitisation following successful treatment with serotonergic antidepressants
S. D. Hood et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Guided and unguided self-help for social anxiety disorder: randomised controlled trial
Tomas Furmark et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder
Henricus G. Ruhe et al.
PHARMACOGENETICS AND GENOMICS (2009)
Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
Lynette C. Daws
PHARMACOLOGY & THERAPEUTICS (2009)
Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-β-(4-iodophenyl)-tropane SPECT
Nic J. van der Wee et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Serotonin and emotional processing: Does it help explain antidepressant drug action?
Catherine J. Harmer
NEUROPHARMACOLOGY (2008)
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C] DASB positron emission tomography
Aristotle N. Voineskos et al.
PSYCHOPHARMACOLOGY (2007)
Reduced serotonin-1A receptor binding in social anxiety disorder
Rupert R. Lanzenberger et al.
BIOLOGICAL PSYCHIATRY (2007)
Treatment of social phobia:: randomised trial of internet-delivered cognitive-behavioural therapy with telephone support
Per Carlbring et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder:: a 123I-ADAM SPECT study
Ana M. Catafau et al.
PSYCHOPHARMACOLOGY (2006)
Internet-based self-help with therapist feedback and in vivo group exposure for social phobia:: A randomized controlled trial
Gerhard Andersson et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2006)
Aberrant accumulation of serotonin in dopaminergic neurons
R Mössner et al.
NEUROSCIENCE LETTERS (2006)
Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM
N Herold et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients
J Cavanagh et al.
BIOLOGICAL PSYCHIATRY (2006)
SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD)
O Pogarell et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry
PD Callaghan et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo
T Furmark et al.
BIOLOGICAL PSYCHIATRY (2005)
Placebo in emotional processing - Induced expectations of anxiety relief activate a generalized modulatory network
P Petrovic et al.
NEURON (2005)
Twelve-month use of Mental Health Services in the United States - Results from the National Comorbidity Survey Replication
PS Wang et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Corelease of dopamine and serotonin from striatal dopamine terminals
FM Zhou et al.
NEURON (2005)
MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
C Svarer et al.
NEUROIMAGE (2005)
Serotonin transporter occupancy of five selective serotonin Reuptake inhibitors at different doses:: An [11C]DASB positron emission tomography study
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets
JA Maldjian et al.
NEUROIMAGE (2003)
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
A Kugaya et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia:: a positron emission tomography study with [11C]McN 5652
JM Kent et al.
PSYCHOPHARMACOLOGY (2002)
Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy
T Furmark et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats
DM Fresco et al.
PSYCHOLOGICAL MEDICINE (2001)
Low dopamine D-2 receptor binding potential in social phobia
FR Schneier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Pharmacokinetics of selective serotonin reuptake inhibitors
C Hiemke et al.
PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
